Ardent Health, Inc. (ARDT) stock
ARDTNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/303% below fair value
$17.75−0.35 (-1.93%)
Close on Nov 17, 2026Market cap $2.50BP/E 32.3Yield –
Ardent Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Ardent Health
Ardent Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?